| Name | 2',3'-Dideoxyadenosine |
|---|---|
| Synonyms |
9-(2,3-dideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine (2′,3′-dideoxyadenosine)
DDA ((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol Dideoxyadenosine, 10 mM in DMSO DIDEOXYADENOSINE ,DDA [(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methanol [(2S,5R)-5-(6-Aminopurin-9-yl)oxolan-2-yl]methanol 2,3-Dideoxyadenosine (ddA) extrapure ddA 9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine EINECS 223-853-2 Didanosine Impurity 7(Didanosine Impurity G) Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine) Didanosine impurity G CRS 9-(2,3-Dideoxy-beta-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-Dideoxyadenosine) 9-(2,3-Dideoxy-β-D-ribofuranosyl)adenine MFCD00010534 Didanosine Related Compound B (2'',3''-dideoxyadenosine) Didanosine Related CoMpound B Dideoxyadenosine //BP DIDEOXYADENOSINE 2',3'-dideoxy adenosine DDA, antiviral drug, related substance B of ddI GL101975 9-(2,3,5-trideoxy-β-D-glycero-pentofuranosyl)-9H-purin-6-amine (2′,3′,5′-trideoxyadenosine) 2',3'-ddA 9-(2,3-Dideoxy-beta-D-glycero-pento 2',3'-DIDEOXYADENOSINE extapure Dideoxyadenosine Didanosine impurity G Adenosine, 2',3'-dideoxy 2', 3'-Dideoxyadenosine 6-Amino-9-(2',3'-dideoxy-b-D-glycero-pentofuranosyl)purine [(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methanol Didanosine Related Compound B (2',3'-dideoxyadenosine) Didanosine Impurity G 2’,3’-dideoxy-adenosin 9-(2,3-Dideoxy-beta-D-ribofuranosyl)adenine BETA-D-2',3'-DIDEOXYADENOSINE Didanosin Imp G 2',3'-Dideoxy-D-adenosine 2',3'-Dideoxyadenosine> ((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)Methanol [(2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydro-2-furanyl]methanol |
| Description | 2',3'-Dideoxyadenosine is an inhibitor of HIV replication[1]. Antiretroviral activity[1]. Antiviral efficacy[1]. |
|---|---|
| Related Catalog | |
| Target |
HIV[1] |
| In Vitro | 2',3'-Dideoxyadenosine inhibits HIV-1 and simian immunodeficiency virus (SIV) in MT-4 cells with EC50s of 5.27 and 5.3 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in human T-lymphocyte CEM cells with EC50s of 4 μM and 8 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in Molt 4/C8 cells with EC50s of 4 μM and 5.5 μM, respectively. 2',3'-Dideoxyadenosine inhibits HIV-1 and HIV-2 in C8166 cells with EC50s of 17 μM and 22 μM, respectively. 2',3'-Dideoxyadenosine inhibits murine sarcoma virus (MSV) in C3H/3T3 cells with an EC50 of 24 μM[1]. |
| References |
| Density | 1.8±0.1 g/cm3 |
|---|---|
| Boiling Point | 539.1±60.0 °C at 760 mmHg |
| Melting Point | 181-184 °C(lit.) |
| Molecular Formula | C10H13N5O2 |
| Molecular Weight | 235.242 |
| Flash Point | 279.9±32.9 °C |
| Exact Mass | 235.106918 |
| PSA | 99.08000 |
| LogP | -0.43 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.822 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | C |
| Risk Phrases | R34 |
| Safety Phrases | 26-27-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | AU7358900 |
| HS Code | 2934999090 |
| Precursor 7 | |
|---|---|
| DownStream 4 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |